How it works

Patient therapy adherence is the major challenge for eye drop treatment

Excess eye drop medication may cause very annoying side effects for patients;

  • Secondary Dry Eye Syndrome
  • Systemic side effects
  • Local Side effects

No excess medication is administered by mu-Drop micro eye drops and therefore is the tolerability very well, secondary Dry Eye Syndrome avoided and systemic and local side effects absent.

mu-Drop micro eye drops drive product quality

  • Versatile, scalable, robust manufacturing technology
  • Cost effective
  • Improved product integrity
  • Preservative free

A mu-Drop micro-drop fits in the eye

A mu-Drop micro-drop single use device delivers a very small micro drop in the eye. Because 10 times less medication is administered the patient may experience the following benefits

  • Significant less local side-effects,
  • Significant less systemic side-effects.

Self-administering of an eye drop is simple and takes very little time (no waiting after administration). Patients should better adhere to their therapy and the therapeutic outcome may increase.

mu-Drop micro-drops are single use

mu-Drop micro drops are packed in either a multi pack blister (e.g. a week medication for Glaucoma patients) or a frozen single pack blister (e.g. human serum for severe Dry Eye Syndrome patients).

In each product are 6 micro eye drops enough to administer medication in each eye. And even in the very unlikely event when the patient makes a mistake there are enough drops to correct.

Continue to read

mu-Drop documentation package

The mu-Drop eye drop technology platform is well documented in accordance with the relevant EP, USP, CE, MDR and ISO guidelines.

mu-Drop also performed bioequivalence, pK and tolerability studies.

mu-Drop makes its documentation available to partners to facilitate and shorten the approval process for Marketing Approval.

Breakthrough: mu-Drop micro eye drops

For many years the medical community is aware that smaller eye drops are as efficient as larger eye drops and because less medication is administered and the micro drop fits in the eye, patients experience less side effects.

Pharma R&D has until recently not resulted in a cost effective micro eye drop which can be manufactured without major investments in equipment and regulatory support.

The mu-Drop device can be post sterilized for administering beta-blockers, aseptically filled for prostaglandins (both Glaucoma) and frozen for holding human serum (severe Dry Eye Syndrome).

The mu-Drop device can prepared for single patients as well as manufactured in large volumes by Big Parma. The manufacturing process is a fully closed system to increase product integrity and patient safety.

Developing micro eye drops is teamwork

mu-Drop micro eye drops can be manufactured very efficiently, are 10 times smaller than classic eye drops and thus require 10 less medication. mu-Drop is licensing the technology to preferred partners.

Contact us